PAI-1: An Integrator of Cell Signaling and Migration
暂无分享,去创建一个
Paul J. Higgins | Craig E. Higgins | Stephen P. Higgins | R. Samarakoon | P. Higgins | R. Czekay | Jessica M. Overstreet | R. M. Klein | Ralf-Peter Czekay | Cynthia E. Wilkins-Port | Jennifer Freytag | R. Matthew Klein | Rohan Samarakoon | J. Freytag | C. Wilkins-Port
[1] R. Czekay,et al. The Low Density Lipoprotein Receptor-related Protein Is a Motogenic Receptor for Plasminogen Activator Inhibitor-1* , 2004, Journal of Biological Chemistry.
[2] B. Degryse,et al. Vitronectin inhibits plasminogen activator inhibitor-1-induced signalling and chemotaxis by blocking plasminogen activator inhibitor-1 binding to the low-density lipoprotein receptor-related protein. , 2009, The international journal of biochemistry & cell biology.
[3] S. Kellouche,et al. Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin , 2010, Tumor Biology.
[4] J. Foidart,et al. PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma , 2010, Journal of oncology.
[5] R. Samarakoon,et al. Integration of non-SMAD and SMAD signaling in TGF-β1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells , 2008, Thrombosis and Haemostasis.
[6] N. Brünner,et al. Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] D. Seiffert,et al. Two functionally distinct pools of vitronectin (Vn) in the blood circulation: identification of a heparin-binding competent population of Vn within platelet alpha-granules. , 1996, Blood.
[8] M. Jo,et al. Low Density Lipoprotein Receptor-related Protein (LRP1) Regulates Rac1 and RhoA Reciprocally to Control Schwann Cell Adhesion and Migration* , 2010, The Journal of Biological Chemistry.
[9] P. Higgins,et al. PAI‐1 gene expression is regionally induced in wounded epithelial cell monolayers and required for injury repair , 2000, Journal of cellular physiology.
[10] F. Blasi,et al. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes , 1997, The EMBO journal.
[11] D. Cheresh,et al. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. , 1991, The Journal of clinical investigation.
[12] R. Balsara,et al. Targeting plasminogen activator inhibitor-1: role in cell signaling and the biology of domain-specific knock-in mice. , 2007, Current drug targets.
[13] A. Gaultier,et al. The Hemopexin Domain of Matrix Metalloproteinase-9 Activates Cell Signaling and Promotes Migration of Schwann Cells by Binding to Low-Density Lipoprotein Receptor-Related Protein , 2008, The Journal of Neuroscience.
[14] R. Aurora,et al. Modulators of cancer cell invasiveness , 2010, Journal of cellular biochemistry.
[15] J. Mazurkiewicz,et al. TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1. , 2009, Cancer research.
[16] M. Bernfield,et al. Regulated Shedding of Syndecan-1 and -4 Ectodomains by Thrombin and Growth Factor Receptor Activation* , 1997, The Journal of Biological Chemistry.
[17] R. Buscà,et al. Transcriptional Signature of Epidermal Keratinocytes Subjected to in Vitro Scratch Wounding Reveals Selective Roles for ERK1/2, p38, and Phosphatidylinositol 3-Kinase Signaling Pathways* , 2007, Journal of Biological Chemistry.
[18] M. Duffy,et al. The urokinase‐type plasminogen activator system in cancer metastasis: A review , 1997, International journal of cancer.
[19] D. Cheresh,et al. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. , 1987, The Journal of biological chemistry.
[20] N. Gibran,et al. Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice. , 2000, Surgery.
[21] Craig E. Higgins,et al. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling. , 2008, Journal of molecular and cellular cardiology.
[22] P. Andreasen,et al. Very Low Density Lipoprotein Receptor Binds and Mediates Endocytosis of Urokinase-type Plasminogen Activator-Type-1 Plasminogen Activator Inhibitor Complex (*) , 1995, The Journal of Biological Chemistry.
[23] S. Hopkinson,et al. Laminin deposition in the extracellular matrix: a complex picture emerges , 2009, Journal of Cell Science.
[24] J. Huntington. Shape-shifting serpins--advantages of a mobile mechanism. , 2006, Trends in biochemical sciences.
[25] Y. Wei,et al. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. , 1997, The Journal of clinical investigation.
[26] W. Campana,et al. Molecular Dissection of the Human α2-Macroglobulin Subunit Reveals Domains with Antagonistic Activities in Cell Signaling* , 2008, Journal of Biological Chemistry.
[27] J. Shute,et al. Plasminogen Activator Inhibitor-1 Supports IL-8-Mediated Neutrophil Transendothelial Migration by Inhibition of the Constitutive Shedding of Endothelial IL-8/Heparan Sulfate/Syndecan-1 Complexes1 , 2003, The Journal of Immunology.
[28] Stephen P. Higgins,et al. pAI-1: A Multifunctional seRpIn with complex Roles in cell signaling and Migration , 2010 .
[29] D. Strickland,et al. LRP: a multifunctional scavenger and signaling receptor. , 2001, The Journal of clinical investigation.
[30] N. Perrimon,et al. The Jak/STAT pathway in model organisms: emerging roles in cell movement. , 2002, Developmental cell.
[31] P. Andreasen,et al. Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasis , 2004, Thrombosis and Haemostasis.
[32] D. Cines,et al. LRP and αvβ3 mediate tPA activation of smooth muscle cells , 2006 .
[33] I. Mikhailenko,et al. Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Forms a Signaling Complex with Platelet-derived Growth Factor Receptor-β in Endosomes and Regulates Activation of the MAPK Pathway* , 2010, The Journal of Biological Chemistry.
[34] D. Lawrence,et al. Old Dogs and New Tricks, Proteases, Inhibitors, and Cell Migration , 2003, Science's STKE.
[35] P. Higgins,et al. PAI‐1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair , 2004, Journal of cellular physiology.
[36] D. Lawrence,et al. Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition. , 1994, The Journal of biological chemistry.
[37] F. Castellino,et al. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. , 2000, Cancer research.
[38] E. Hurt,et al. Identification of Vitronectin as an Extrinsic Inducer of Cancer Stem Cell Differentiation and Tumor Formation , 2009, Stem cells.
[39] F. Tang,et al. Cellular growth inhibition by IGFBP‐3 and TGF‐β1 requires LRP‐1 , 2003 .
[40] D. Seiffert. Constitutive and regulated expression of vitronectin. , 1997, Histology and histopathology.
[41] Richard G. W. Anderson,et al. LRP: Role in Vascular Wall Integrity and Protection from Atherosclerosis , 2003, Science.
[42] E. Ruoslahti,et al. A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[43] J. Wilcox,et al. Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. , 1995, Journal of cell science.
[44] M. Iruela-Arispe,et al. Distribution of vitronectin mRNA during murine development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.
[45] S. Pawar,et al. Differential gene expression in migrating renal epithelial cells after wounding , 1995, Journal of cellular physiology.
[46] D. Lawrence,et al. Plasminogen activator inhibitor‐1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices , 2010, Journal of thrombosis and haemostasis : JTH.
[47] R. Orlando,et al. The Low Density Lipoprotein Receptor-related Protein Complexes with Cell Surface Heparan Sulfate Proteoglycans to Regulate Proteoglycan-mediated Lipoprotein Catabolism* , 2003, The Journal of Biological Chemistry.
[48] D. Loskutoff,et al. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? , 1996, The Journal of cell biology.
[49] R. Czekay,et al. Plasminogen activator inhibitor‐1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin , 2001, Journal of cellular physiology.
[50] P. Charlton,et al. Plasminogen Activator Inhibitor-1 Supports IL-8-Mediated Neutrophil Transendothelial Migration by Inhibition of the Constitutive Shedding of Endothelial IL-8/Heparan Sulfate/Syndecan-1 Complexes , 2003, The Journal of Immunology.
[51] P. Carmeliet,et al. Plasminogen Activator Inhibitor-1 Regulates Integrin αvβ3 Expression and Autocrine Transforming Growth Factor β Signaling* , 2009, The Journal of Biological Chemistry.
[52] P. McKeown-Longo,et al. Vitronectin's Basic Domain is a Syndecan Ligand which Functions in transto Regulate Vitronectin Turnover , 2003, Cell communication & adhesion.
[53] Craig E. Higgins,et al. PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes. , 2010, The Journal of investigative dermatology.
[54] D. Cheresh,et al. Purification and functional characterization of integrin alpha v beta 5. An adhesion receptor for vitronectin. , 1990, The Journal of biological chemistry.
[55] P. Andreasen,et al. Vitronectin in human breast carcinomas. , 2003, Biochimica et biophysica acta.
[56] M. Schmitt,et al. Prognostische Bedeutung des Plasminogenaktivators vom Urokinasetyp (uPA) und des Plasminogenaktivator-Inhibitors (PAI-1) beim primär resezierten Plattenepithelkarzinom der Mundhöhle , 2004, Mund-, Kiefer- und Gesichtschirurgie.
[57] D. Mock,et al. Profiling motility signal-specific genes in primary human keratinocytes. , 2008, The Journal of investigative dermatology.
[58] R. Czekay,et al. Plasminogen activator inhibitors regulate cell adhesion through a uPAR‐dependent mechanism , 2009, Journal of cellular physiology.
[59] S. Futaki,et al. Kinetic Analysis of the Interaction between Vitronectin and the Urokinase Receptor* , 2002, The Journal of Biological Chemistry.
[60] P. Declerck,et al. Inactivation of Plasminogen Activator Inhibitor-1 by Specific Proteolysis with Stromelysin-1 (MMP-3)* , 2000, The Journal of Biological Chemistry.
[61] R. Czekay,et al. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins , 2003, The Journal of cell biology.
[62] G. Inoue,et al. Ligand Binding to LRP1 Transactivates Trk Receptors by a Src Family Kinase–Dependent Pathway , 2009, Science Signaling.
[63] Wen-Fang Tseng,et al. LRP‐1/TβR‐V mediates TGF‐β1‐induced growth inhibition in CHO cells , 2004 .
[64] R. Czekay,et al. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. , 2001, Molecular biology of the cell.
[65] T. Krieg,et al. Integrin expression in the dermis during scar formation in humans , 2002, Experimental dermatology.
[66] Y. Takayama,et al. LRP1 Regulates Architecture of the Vascular Wall by Controlling PDGFRβ-Dependent Phosphatidylinositol 3-Kinase Activation , 2009, PloS one.
[67] K. Rubin,et al. Vitronectin in colorectal adenocarcinoma--synthesis by stromal cells in culture. , 1994, Experimental cell research.
[68] M. Stack,et al. Processing of Laminin-5 and Its Functional Consequences: Role of Plasmin and Tissue-type Plasminogen Activator , 1998, The Journal of cell biology.
[69] D. Cheresh. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[70] J. Mimuro,et al. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells. , 1989, The Journal of biological chemistry.
[71] A. Eddy,et al. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. , 2001, Kidney international.
[72] F. Carreiras,et al. Mesothelial vitronectin stimulates migration of ovarian cancer cells , 2010, Cell biology international.
[73] D. Ann,et al. Crosstalk of hypoxia‐mediated signaling pathways in upregulating plasminogen activator inhibitor‐1 expression in keloid fibroblasts , 2004, Journal of cellular physiology.
[74] Y. Eguchi,et al. Detection of vitronectin mRNA in tissues and cells of the mouse. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[75] S. Hill,et al. Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line. , 1996, Blood.
[76] J. Mimuro,et al. Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin. , 1989, The Journal of biological chemistry.
[77] P. Declerck,et al. Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive-site loop. , 1994, The Journal of biological chemistry.
[78] C. Gahmberg,et al. LDL-receptor-related protein regulates beta2-integrin-mediated leukocyte adhesion. , 2005, Blood.
[79] M. D. Evans,et al. Vitronectin is present in epithelial cells of the intact lens and promotes epithelial mesenchymal transition in lens epithelial explants. , 2006, Molecular vision.
[80] Richard G. W. Anderson,et al. LRP1 Functions as an Atheroprotective Integrator of TGFβ and PDGF Signals in the Vascular Wall: Implications for Marfan Syndrome , 2007, PloS one.
[81] K. Itoh,et al. Induction of glioma cell migration by vitronectin in human serum and cerebrospinal fluid. , 2007, Journal of neurosurgery.